Learn More
Selleck Chemical LLC Tivantinib (ARQ 197) 10mg 905854-02-6

Supplier: Selleck Chemical LLC S275310MG
Tivantinib (ARQ 197) is the first non-ATP-competitive c-Met inhibitor with Ki of 0.355 ?M in a cell-free assay, little activity to Ron, and no inhibition to EGFR, InsR, PDGFR? or FGFR1/4. Tivantinib (ARQ 197) induces a G2/M arrest and apoptosis. Phase 3. *For Research & Development use only. Product is not intended for drug, household, or human consumption.
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.